ARCHIVES

Combine Phase 1-2, Abolish DRG, Slash Indirect Costs, Garb Tells Congress

This article is from The Cancer Letter archive.

Vol. 07 No. 48 | November 27, 1981

Download PDF Visit The Full Archive

Related Articles

In Brief: House Passes Bill Extending Saccharin Status To 1981; Execs No Enthusiastic Over New SES

August 3, 1979

Amid Protests Over Grant Paylines, NCI’s Niederhuber Tells Scientists To Get “Leaner And Better”.

April 7, 2006

Abstracts Of Papers From Copenhagen Leukemia Symposium

October 24, 1975

FDA, NIH Streamline Approvals For Gene Therapy Studies

June 16, 1995

NCI clinical trials cooperative group chairmen reject specimen bank contract proposal, endorse cooperative agreements;

January 2, 2004

Sustained-Release Leuprolide Under Study In Phase III Trial.

June 30, 2000